ci - cubitus interruptus Gene

Also Known as Ce; CG2125; Ci; CI; ci-D; Ci/Gli; Ci/GLI; ci155; Ci155; ciA; ciD; CiD; CID; ciR; ci[D]; Ci[D]; d Ci; Dmel\CG2125; Gli; l(4)102ABc; l(4)13; l(4)17; Siah

Species: Drosophila melanogaster

Gene Type: protein coding

Gene ID: 43767

Summary

Enables several functions, including DNA-binding transcription activator activity, RNA polymerase II-specific; cAMP response element binding protein binding activity; and protein homodimerization activity. Involved in several processes, including animal organ development; regionalization; and regulation of transcription by RNA polymerase II. Located in cytosol; membrane; and nucleus. Part of Hedgehog signaling complex. Is expressed in several structures, including ectoderm; ectoderm anlage; embryonic epidermis; extended germ band embryo; and imaginal disc. Used to study primary Bacterial infectious disease. Human ortholog(s) of this gene implicated in several diseases, including Culler-Jones syndrome; Pallister-Hall syndrome; anodontia; holoprosencephaly 9; and synostosis (multiple). Orthologous to several human genes including GLI2 (Gli family zinc finger 2) and GLI3 (Gli family zinc finger 3). [provided by Alliance of Genome Resources, Apr 2022]

ci Products (3)

mRNA	Protein	Name
NM_001258473.1	NP_001245402.1	cubitus interruptus, isoform B [Drosophila melanogaster]
NM_001258472.2	NP_001245401.1	cubitus interruptus, isoform C [Drosophila melanogaster]
NM_079878.5	NP_524617.3	cubitus interruptus, isoform A [Drosophila melanogaster]

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables DNA-binding transcription activator activity, RNA polymerase II-specific	IGI IGI: Inferred from genetic interaction	10669739	FlyBase
enables DNA-binding transcription activator activity, RNA polymerase II-specific	IMP IMP: Inferred from mutant phenotype	20403347	FlyBase
enables DNA-binding transcription factor activity, RNA polymerase II-specific	IDA IDA: Inferred from direct assay	8769644	FlyBase
enables DNA-binding transcription factor activity, RNA polymerase II-specific	IMP IMP: Inferred from mutant phenotype	25941387	FlyBase
enables RNA polymerase II transcription regulatory region sequence-specific DNA binding	IDA IDA: Inferred from direct assay	9122207	FlyBase
enables cAMP response element binding protein binding	IPI IPI: Inferred from physical interaction	25941387	FlyBase
enables protein binding	IPI IPI: Inferred from physical interaction	9109493	FlyBase
enables protein homodimerization activity	IDA IDA: Inferred from direct assay	19955409	FlyBase
enables protein kinase binding	IDA IDA: Inferred from direct assay	26403189	FlyBase
enables sequence-specific DNA binding	IDA IDA: Inferred from direct assay	9215627	FlyBase
enables transcription cis-regulatory region binding	IDA IDA: Inferred from direct assay	20226779	FlyBase

Biological Process GO Annotation	Evidence	References	Source
involved in compound eye morphogenesis	IMP IMP: Inferred from mutant phenotype	16651542	FlyBase
involved in cuticle pattern formation	IMP IMP: Inferred from mutant phenotype	16413529	FlyBase
involved in dendrite morphogenesis	IMP IMP: Inferred from mutant phenotype	23977298	FlyBase
involved in genital disc anterior/posterior pattern formation	IEP IEP: Inferred from expression pattern	8798147	FlyBase
involved in heart formation	IMP IMP: Inferred from mutant phenotype	8660881	FlyBase
involved in labial disc development	IMP IMP: Inferred from mutant phenotype	15680366	FlyBase
involved in mucosal immune response	IMP IMP: Inferred from mutant phenotype	25639794	FlyBase
involved in negative regulation of hippo signaling	IGI IGI: Inferred from genetic interaction	26403189	FlyBase
involved in negative regulation of transcription by RNA polymerase II	IGI IGI: Inferred from genetic interaction	16386907	FlyBase
involved in negative regulation of transcription by RNA polymerase II	IMP IMP: Inferred from mutant phenotype	8769644	FlyBase
involved in positive regulation of G1/S transition of mitotic cell cycle	IMP IMP: Inferred from mutant phenotype	15809036	FlyBase
involved in positive regulation of epithelial cell differentiation	IMP IMP: Inferred from mutant phenotype	18633350	FlyBase
involved in positive regulation of transcription by RNA polymerase II	IDA IDA: Inferred from direct assay	9122207	FlyBase
involved in positive regulation of transcription by RNA polymerase II	IGI IGI: Inferred from genetic interaction	10669739	FlyBase
involved in positive regulation of transcription by RNA polymerase II	IMP IMP: Inferred from mutant phenotype	8769644	FlyBase
involved in regulation of cell proliferation involved in compound eye morphogenesis	IMP IMP: Inferred from mutant phenotype	17559828	FlyBase
involved in regulation of mitotic cell cycle	IMP IMP: Inferred from mutant phenotype	11279500	FlyBase
involved in segment polarity determination	IMP IMP: Inferred from mutant phenotype	2166702	FlyBase
involved in smoothened signaling pathway	IDA IDA: Inferred from direct assay	9215627	FlyBase
involved in smoothened signaling pathway	IEP IEP: Inferred from expression pattern	8898240	FlyBase
involved in smoothened signaling pathway	IGI IGI: Inferred from genetic interaction	7577671	FlyBase
involved in smoothened signaling pathway	IMP IMP: Inferred from mutant phenotype	8658135	FlyBase
involved in spiracle morphogenesis, open tracheal system	IMP IMP: Inferred from mutant phenotype	15930099	FlyBase
involved in wing disc anterior/posterior pattern formation	IMP IMP: Inferred from mutant phenotype	15708556	FlyBase

Cellular Component GO Annotation	Evidence	References	Source
part of Hedgehog signaling complex	IPI IPI: Inferred from physical interaction	9244297	FlyBase
located in cytosol	IDA IDA: Inferred from direct assay	7577671	FlyBase
located in nucleus	IDA IDA: Inferred from direct assay	7577671	FlyBase
part of protein-containing complex	IPI IPI: Inferred from physical interaction	9601642	FlyBase

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Protein Preferred Names	Protein Names
cubitus interruptus	CG2125-PA CG2125-PB CG2125-PC cell ci-PA ci-PB ci-PC cubitis interruptus cubitus cubitus interuptus cubitus-interruptus cubitus-interruptus-Dominant interruptus

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (23)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B1102	Evans Blue	Inhibitor	99.86%	Unkown
HY-17379	Atorvastatin hemicalcium salt		99.94%	Yes
HY-14536	Methylene Blue	Inhibitor	95.05%	Unkown
HY-A0006	Pentostatin	Inhibitor	99.93%	Yes
HY-B0258	Gemfibrozil		99.91%	Yes
HY-B0124	Zonisamide	Inhibitor	99.95%	Yes
HY-10373	Trimetrexate	Inhibitor	99.60%	Unkown
HY-B1359	Methylene blue trihydrate	Inhibitor	98.0%	Yes
HY-B0308	Sparfloxacin	Inhibitor	99.93%	Unkown
HY-17455	Pramiracetam	Inhibitor	98.21%	Unkown
HY-B0136	Cefdinir	Inhibitor	98.67%	Unkown
HY-B0268A	Enoxacin hydrate		99.85%	Yes
HY-B0477	Quinapril hydrochloride	Inhibitor	98.30%	Yes
HY-D0958	Methylene blue hydrate	Inhibitor	/	Unkown
HY-B0268	Enoxacin		98.67%	Yes
HY-100795A	Pirmenol hydrochloride	Inhibitor	99.34%	Unkown
HY-103396	Trimetrexate glucuronate		98.09%	Yes
HY-17379R	Atorvastatin hemicalcium salt (Standard)		99.65%	Unkown
HY-B0124A	Zonisamide sodium	Inhibitor	/	Unkown
HY-100795	Pirmenol	Inhibitor	99.32%	Unkown
HY-10373A	Trimetrexate trihydrochloride	Inhibitor	/	Unkown
HY-10373B	Trimetrexate isethionate	Inhibitor	/	Unkown
HY-B0477A	Quinapril	Inhibitor	/	Unkown

Clinical Phase

Bioactive Molecules (18)

Cat. No.	Product Name	Effect	Purity	Phase
HY-13215	Avasimibe	Inhibitor	99.85%	Phase 3
HY-50934	Tacedinaline		99.32%	Phase 3
HY-101438	Darbufelone	Inhibitor	99.49%	Phase 3
HY-135460	Milameline	Agonist	/	Phase 3
HY-N1201	Apigenin		99.22%	Phase 2
HY-50295	CI-1040		99.91%	Phase 2
HY-10367	Canertinib	Inhibitor	99.74%	Phase 2
HY-107572	PD 128042	Inhibitor	99.97%	Phase 2
HY-10367A	Canertinib dihydrochloride	Inhibitor	99.68%	Phase 2
HY-139558	Zapnometinib	Inhibitor	99.85%	Phase 2
HY-105235	Enadoline	Agonist	/	Phase 2
HY-106091	Losoxantrone		/	Phase 2
HY-19186	PD-143188	Agonist	/	Phase 2
HY-105403	Besonprodil	Antagonist	/	Phase 1
HY-106090	Teloxantrone	Inhibitor	/	Phase 1
HY-123240	CI-966	Inhibitor	/	Phase 1
HY-19108	CI-959	Inhibitor	/	Phase 1
HY-19128	CI-990	Inhibitor	/	Phase 1

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P99040	Onvatilimab	Inhibitor	98.00%	Phase 1

Pre-clinical Phase

Bioactive Molecules (231)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-N0822	Shikonin	Inhibitor	99.80%	Unkown
HY-16909	Leptomycin B	Inhibitor	99.79%	Unkown
HY-129993	Gemfibrozil 1-O-β-glucuronide	Inhibitor	99.87%	Unkown
HY-B0919	Azaserine	Inhibitor	99.96%	Unkown
HY-D0914	Fast Green FCF	Inhibitor	99.95%	Unkown
HY-D0971	Pyronin Y		83.71%	Unkown
HY-N0408	Picroside II		99.91%	Unkown
HY-D0256	Direct Black 38		/	Unkown
HY-123630	Allura Red AC		99.00%	Unkown
HY-D0249	Sunset Yellow FCF		98.0%	Unkown
HY-126222A	MitoTam iodide, hydriodide		98.83%	Unkown
HY-14536A	Methylene blue (purity≥70%)	Inhibitor	95.0%	Unkown
HY-N1201R	Apigenin (Standard)		98.82%	Unkown
HY-139010	Merafloxacin	Inhibitor	98.04%	Unkown
HY-D0932	Sudan IV		98.0%	Unkown
HY-121577	Sonlicromanol	Modulator	98.65%	Unkown
HY-D0983	Trypan red		/	Unkown
HY-Y0057	NSC 13138		99.58%	Unkown
HY-W110927	Alizarin Red S Indicator (4.3-6.3), IND		95%	Unkown
HY-126222	MitoTam bromide, hydrobromide		/	Unkown
HY-D0376	Solvent Yellow 93		98.40%	Unkown
HY-W110929	Acid blue 1		91.07%	Unkown
HY-W074717	7-Octynylamine (7CI,8CI)		99.25%	Unkown
HY-Y0007	N-[(Benzyloxy)carbonyl]-L-alanine		99.38%	Unkown
HY-W393243	3′-O-Methyladenosine		99.66%	Unkown
HY-103534	CI-966 hydrochloride	Inhibitor	99.60%	Unkown
HY-79415	4-Methyl-L-leucine		97.0%	Unkown
HY-B0258R	Gemfibrozil (Standard)		99.82%	Unkown
HY-B0536	Clinafloxacin	Inhibitor	99.87%	Unkown
HY-D0491	C.I. Disperse blue 79		/	Unkown
HY-100246	CI-1044	Inhibitor	98.02%	Unkown
HY-155554	SCAL-255		99.15%	Unkown
HY-W110884	Eriochrome cyanine R indicator (C.I. 43820)		85.0%	Unkown
HY-D0478	C.I. Basic red 14		99.09%	Unkown
HY-106045	Imazodan	Inhibitor	99.38%	Unkown
HY-79046	Boc-L-2-aminobutanoic acid		98.0%	Unkown
HY-79404	N-(Tert-Butoxycarbonyl)-L-neopentylglycine		98.52%	Unkown
HY-D0421	C.I. Solvent yellow 18		98.45%	Unkown
HY-Y1033S	Methyl-triphenylphosphonium-d3 bromide		99.0%	Unkown
HY-100032	PD 117519	Agonist	99.97%	Unkown
HY-B0258S	Gemfibrozil-d6		98.71%	Unkown
HY-101438A	Darbufelone mesylate	Inhibitor	99.65%	Unkown
HY-105226B	CI-988 hemihydrate	Antagonist	≥99.0%	Unkown
HY-106702	Fostriecin sodium	Inhibitor	95.00%	Unkown
HY-10724	Fidexaban	Inhibitor	99.62%	Unkown
HY-119602	Rolziracetam		99.50%	Unkown
HY-79417	(S)-N-Methyl-N-methoxy-2-(tert-butoxycarbonylamino)-4-methylpentanamide		/	Unkown
HY-79491	(S)-2-Aminobutyramide hydrochloride		≥98.0%	Unkown
HY-B0536A	Clinafloxacin hydrochloride	Inhibitor	99.58%	Unkown
HY-D1137	C.I. Pigment yellow 110		/	Unkown
HY-W775174	Citrus red 2		99.57%	Unkown
HY-106702A	Fostriecin	Inhibitor	/	Unkown
HY-D0429	C.I. Pigment red 5		/	Unkown
HY-D0492	C.I. Basic blue 41		93.46%	Unkown
HY-D0531	C.I. Pigment red 123		98.01%	Unkown
HY-D1242	CI Vat green 1		/	Unkown
HY-W249257	4-Bromobenzoic acid-d4		98.09%	Unkown
HY-W344938	C.I. Acid yellow 3		/	Unkown
HY-100161	CI-943	Antagonist	/	Unkown
HY-100266	Nitromifene	Antagonist	/	Unkown
HY-103459	CI-1020	Antagonist	/	Unkown
HY-105226	CI-988	Antagonist	/	Unkown
HY-105226A	CI-988 meglumin	Antagonist	/	Unkown
HY-105235A	Enadoline hydrochloride	Agonist	/	Unkown
HY-105236	(Rac)-Enadoline	Agonist	/	Unkown
HY-105504	CI-986	Inhibitor	/	Unkown
HY-105627A	Profadol hydrochloride		/	Unkown
HY-105628	Prodilidine		/	Unkown
HY-105628A	Prodilidine hydrochloride		/	Unkown
HY-106045A	Imazodan hydrochloride	Inhibitor	/	Unkown
HY-106091B	Losoxantrone hydrochloride		/	Unkown
HY-106305	Ledoxantrone	Inhibitor	/	Unkown
HY-106305A	Ledoxantrone trihydrochloride	Inhibitor	/	Unkown
HY-106685	Selenazofurin		/	Unkown
HY-106740	CI-933	Inhibitor	/	Unkown
HY-106752	CI-936	Agonist	/	Unkown
HY-106995	PD 172760	Antagonist	/	Unkown
HY-107650	Milameline hydrochloride	Agonist	/	Unkown
HY-107650A	Milameline hydroiodide	Agonist	96.25%	Unkown
HY-108035	(-)-JM-1232		/	Unkown
HY-113886	CI-959 free acid		/	Unkown
HY-115895	Trebenzomine	Inhibitor	/	Unkown
HY-117871	Naphthol AS-OL	Substrate	99.05%	Unkown
HY-118047	CI 972 anhydrous	Inhibitor	/	Unkown
HY-118314	CI-1015		/	Unkown
HY-119146	Zolazepam		/	Unkown
HY-119795	Zometapine		/	Unkown
HY-122133	CI 750		/	Unkown
HY-123555	PD 142505-0028		/	Unkown
HY-124254	C.I. Vat Yellow 2		/	Unkown
HY-126222B	(E/Z)-MitoTam iodide, hydriodide		95.66%	Unkown
HY-139801	Indolapril hydrochloride	Inhibitor	/	Unkown
HY-155555	SCAL-266	Inhibitor	/	Unkown
HY-157954	WRN inhibitor 6		/	Unkown
HY-161992	Nrf2 activator-11		/	Unkown
HY-168722	PROTAC PARP1 degrader-3	Degrader	/	Unkown
HY-179534	G13Ci-22	Inhibitor	/	Unkown
HY-180185	5-HT2A&5-HT2C agonist-2	Agonist	/	Unkown
HY-181430	PXS 25	Inhibitor	/	Unkown
HY-19165	CI-996	Antagonist	/	Unkown
HY-19181	CI-1002		/	Unkown
HY-50295A	CI-1040 hydrochloride		/	Unkown
HY-B0308S	Sparfloxacin-d5	Inhibitor	/	Unkown
HY-D0256A	Direct Black 38 free acid		/	Unkown
HY-D0293	Acid blue 1 free acid		98.24%	Unkown
HY-D0420	C.I. Acid red 151		/	Unkown
HY-D0425	C.I. Direct red 84		/	Unkown
HY-D0450	C.I. Pigment red 112		/	Unkown
HY-D0523	C.I. Food Blue 5:2		/	Unkown
HY-D0573	C.I. Solvent red 197		/	Unkown
HY-D0678	C.I. Reactive yellow 86		/	Unkown
HY-D0960	C.I. Solvent Blue 43		/	Unkown
HY-D1123	Indigosol brown IBR		/	Unkown
HY-RS09151	NDUFB6 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W001273	Pramiracetam sulfate	Inhibitor	/	Unkown
HY-W699866	Gemfibrozil 1-O-β-glucuronide-d6		/	Unkown
HY-W754370	Methyltriphenylphosphonium bromide-13C,d3		/	Unkown
HY-W874904	C.I. Solvent Yellow 33		/	Unkown
HY-Y0225S	p-Fluorophenol-d6		98.5%	Unkown
HY-105392	LB30057	Inhibitor	/	Unkown
HY-106090A	Teloxantrone hydrochloride hydrate	Inhibitor	/	Unkown
HY-115231	ci-IP3/PM		/	Unkown
HY-121774	Naphthol AS-ITR		/	Unkown
HY-129721	Acid Red 26		/	Unkown
HY-13552	Asulacrine isethionate	Inhibitor	/	Unkown
HY-138237	25I-NBMD hydrochloride	Agonist	/	Unkown
HY-146364	CI-39	Inhibitor	/	Unkown
HY-155222	TW9	Inhibitor	/	Unkown
HY-169837	PD-147693		/	Unkown
HY-174571	Human NEUROG2 mRNA		/	Unkown
HY-180273	Antibacterial agent 309	Inhibitor	/	Unkown
HY-183455	CI-930	Inhibitor	/	Unkown
HY-183480	Asulacrine		/	Unkown
HY-19145	PD-134672	Inhibitor	/	Unkown
HY-34410	(R)-2-Aminopent-4-enoic acid hydrochloride		/	Unkown
HY-B0124S2	Zonisamide-13C6	Inhibitor	/	Unkown
HY-B0136S	Cefdinir-13C,15N2	Inhibitor	/	Unkown
HY-B0258S1	Gemfibrozil-d6-1		/	Unkown
HY-B0477AS1	Quinapril-d5 hydrochloride		/	Unkown
HY-B0477AS2	Quinapril-d4	Inhibitor	/	Unkown
HY-D0314	Solvent Red 1 (C.I.)		/	Unkown
HY-D0319	C.I. Basic Blue 8		/	Unkown
HY-D0351	Fluorescent Brightener 134		/	Unkown
HY-D0391	C.I Acid orange 8		/	Unkown
HY-D0394	C.I. Pigment red 2		/	Unkown
HY-D0395	C.I. Mordant Orange 29		/	Unkown
HY-D0396	C.I. Direct red 16		/	Unkown
HY-D0397	C.I. Direct Violet 9		/	Unkown
HY-D0399	C.I. Acid blue 40		/	Unkown
HY-D0400	C.I. Disperse yellow 23		/	Unkown
HY-D0405	C.I. Pigment yellow 74		/	Unkown
HY-D0406	C.I. Basic yellow 37		/	Unkown
HY-D0407	C.I. Acid black 94		/	Unkown
HY-D0408	C.I. Pigment red 38		/	Unkown
HY-D0409	C.I. Mordant yellow 8		/	Unkown
HY-D0410	C.I. Acid yellow 200		/	Unkown
HY-D0412	C.I. Acid yellow 48		/	Unkown
HY-D0413	C.I. Acid red 37		/	Unkown
HY-D0414	C.I. Acid blue 158		/	Unkown
HY-D0415	C.I. Vat blue 22		/	Unkown
HY-D0417	C.I. Acid orange 3		/	Unkown
HY-D0418	C.I. Acid yellow 42		/	Unkown
HY-D0419	C.I. Direct green 26		/	Unkown
HY-D0422	C.I. Acid red 183		/	Unkown
HY-D0423	C.I. Acid green 27		/	Unkown
HY-D0424	C.I. Acid blue 25		/	Unkown
HY-D0426	C.I. Pigment red 8		/	Unkown
HY-D0427	C.I. Pigment red 12		/	Unkown
HY-D0428	C.I. Pigment red 9		/	Unkown
HY-D0431	C.I. Pigment blue 56		/	Unkown
HY-D0433	C.I. Vat Blue 16		/	Unkown
HY-D0434	C.I. Acid blue 40 sodium salt		/	Unkown
HY-D0435	C.I. Acid brown 120		/	Unkown
HY-D0436	C.I. Direct black 32		/	Unkown
HY-D0437	C.I. Direct blue 75		/	Unkown
HY-D0438	C.I. Acid red 114		/	Unkown
HY-D0439	C.I. Mordant yellow 12		/	Unkown
HY-D0440	C.I. Direct green 28		/	Unkown
HY-D0441	C.I. Pigment red 23		/	Unkown
HY-D0442	C.I. Pigment red 14		/	Unkown
HY-D0443	C.I. Direct black 22		/	Unkown
HY-D0444	C.I. Acid brown 121		/	Unkown
HY-D0445	C.I. Pigment orange 16		/	Unkown
HY-D0446	C.I. Acid orange 33		/	Unkown
HY-D0447	C.I. Acid red 374		/	Unkown
HY-D0448	C.I. Acid red 154		/	Unkown
HY-D0451	C.I. Direct orange 102		/	Unkown
HY-D0452	C.I. Acid brown 75		/	Unkown
HY-D0454	C.I. Disperse red 54		/	Unkown
HY-D0456	C.I. Direct violet 66		/	Unkown
HY-D0457	C.I. Solvent red 179		/	Unkown
HY-D0458	C.I. Acid red 106		/	Unkown
HY-D0459	C.I. Pigment brown 25		/	Unkown
HY-D0460	C.I. Pigment red 48		/	Unkown
HY-D0465	C.I. Direct black 80		/	Unkown
HY-D0472	C.I. Acid red 97		/	Unkown
HY-D0473	C.I. Direct yellow 27		/	Unkown
HY-D0476	C.I. Acid yellow 99		/	Unkown
HY-D0477	C.I. Acid red 57		/	Unkown
HY-D0480	C.I. Acid black 60		/	Unkown
HY-D0481	C.I. Acid orange 67		/	Unkown
HY-D0482	C.I. Direct blue 80		/	Unkown
HY-D0484	C.I. Disperse yellow 70		/	Unkown
HY-D0486	C.I. Pigment violet 32		/	Unkown
HY-D0487	C.I. Pigment yellow 97		/	Unkown
HY-D0488	C.I. Pigment orange 36		/	Unkown
HY-D0489	C.I. Pigment orange 38		/	Unkown
HY-D0490	C.I. Acid yellow 49		/	Unkown
HY-D0493	C.I. Pigment yellow 62		/	Unkown
HY-D0494	C.I. Acid yellow 151		/	Unkown
HY-D0495	C.I. Acid brown 83		/	Unkown
HY-D0496	C.I. Mordant green 17		/	Unkown
HY-D0497	C.I. Disperse orange 37		/	Unkown
HY-D0508	C.I. Acid red 138		/	Unkown
HY-D0509	C.I. Acid yellow 172		/	Unkown
HY-D0510	C.I. Pigment orange 34		/	Unkown
HY-D0519	C.I. Pigment red 52:1		/	Unkown
HY-D0536	C.I. Acid black 132		/	Unkown
HY-D0551	C.I. Basic red 24		/	Unkown
HY-D0555	C.I. Disperse orange 73		/	Unkown
HY-D0559	C.I. Disperse blue 284		/	Unkown
HY-D0560	C.I. Pigment red 247		/	Unkown
HY-D0590	C.I. Pigment red 187		/	Unkown
HY-D0597	C.I. Mordant red 94		/	Unkown
HY-D0643	C.I. Disperse orange 33		/	Unkown
HY-D0686	C.I. Pigment red 221		/	Unkown
HY-D0725	C.I. Pigment yellow 180		/	Unkown
HY-D0932S	Sudan IV-d6		/	Unkown
HY-W516943	CI-624	Inhibitor	/	Unkown
HY-W667933	S-Propyl-L-cysteine sulfoxide		/	Unkown
HY-U00364	CI-949	Inhibitor	/	Unkown

Bioactive MoleculesInhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P990246	Anti-Mouse F4/80 Antibody (CI:A3-1)	Inhibitor	95.00%	Unkown